Zymeworks (ZYME) Current Taxes (2022 - 2026)
Zymeworks (ZYME) posted Current Taxes of $66000.0 for Q1 2026, down 20.48% sequentially from $83000.0 in Q4 2025, and down 48.03% YoY from $127000.0 in Q1 2025.
Powered by 
Analysis
Zymeworks (ZYME) Current Taxes (2022 - 2026) Analysis & Trends
Zymeworks has reported Current Taxes for 5 years, with the latest figure at $66000.0 in Q1 2026.
- Quarterly Current Taxes fell 48.03% year-over-year to $66000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66000.0 (down 48.03% YoY) and the FY2025 annual result came in at $83000.0, down 35.16% from the prior year.
- Current Taxes declined to $66000.0 in Q1 2026 per ZYME's latest filing, from $83000.0 in the prior quarter.
- Over five years, Current Taxes peaked at $2.1 million in Q3 2024 and troughed at $66000.0 in Q1 2026.
- A 5-year average of $919142.9 and a median of $840000.0 in 2022 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2024 and 2025: Current Taxes soared 149.22% in 2024, then sank 94.73% in 2025.
- Over 5 years, Current Taxes stood at $840000.0 in 2022, then soared by 115.6% to $1.8 million in 2023, then slumped by 92.93% to $128000.0 in 2024, then plunged by 35.16% to $83000.0 in 2025, then fell by 20.48% to $66000.0 in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $66000.0, $83000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - | 45,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45,000.00 |
| Mar 31, 2026 | 66,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 127,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 831,000.00 |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 840,000.00 |
| Dec 31, 2022 | 840,000.00 |